[go: up one dir, main page]

IL69374A0 - Process for the preparation of a herpes antigen,an agent suitable for this and a process for its preparation,and the use of this antigen - Google Patents

Process for the preparation of a herpes antigen,an agent suitable for this and a process for its preparation,and the use of this antigen

Info

Publication number
IL69374A0
IL69374A0 IL69374A IL6937483A IL69374A0 IL 69374 A0 IL69374 A0 IL 69374A0 IL 69374 A IL69374 A IL 69374A IL 6937483 A IL6937483 A IL 6937483A IL 69374 A0 IL69374 A0 IL 69374A0
Authority
IL
Israel
Prior art keywords
preparation
antigen
agent suitable
herpes
hsv
Prior art date
Application number
IL69374A
Other languages
English (en)
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of IL69374A0 publication Critical patent/IL69374A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL69374A 1982-07-30 1983-07-29 Process for the preparation of a herpes antigen,an agent suitable for this and a process for its preparation,and the use of this antigen IL69374A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823228501 DE3228501A1 (de) 1982-07-30 1982-07-30 Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens

Publications (1)

Publication Number Publication Date
IL69374A0 true IL69374A0 (en) 1983-11-30

Family

ID=6169723

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69374A IL69374A0 (en) 1982-07-30 1983-07-29 Process for the preparation of a herpes antigen,an agent suitable for this and a process for its preparation,and the use of this antigen

Country Status (7)

Country Link
EP (1) EP0100521B1 (xx)
JP (1) JPS5948095A (xx)
AT (1) ATE56044T1 (xx)
AU (1) AU577516B2 (xx)
CA (1) CA1273884A (xx)
DE (2) DE3228501A1 (xx)
IL (1) IL69374A0 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT77014B (en) * 1982-07-20 1986-01-24 Molecular Genetics Inc Production of herpes simplex viral proteins
US4818694A (en) * 1982-07-20 1989-04-04 American Cyanamid Company Production of herpes simplex viral protein
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
JPS6051120A (ja) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニットワクチン
US4642333A (en) * 1983-09-16 1987-02-10 Stanley Person Immunologically reactive non-glycosylated amino acid chains of glycoprotein B of herpes virus types 1 and 2
EP0175787B1 (en) * 1984-04-06 1995-02-15 Chiron Corporation RECOMBINANT HERPES SIMPLEX gB-gD VACCINE
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
JPS615786A (ja) * 1984-06-19 1986-01-11 Chemo Sero Therapeut Res Inst 単純ヘルペスウイルス遺伝子を組込んだ組換えｄｎａ、形質転換動物細胞および単純ヘルペスウイルス蛋白質の製法
DE3582200D1 (de) * 1984-07-20 1991-04-25 Chemo Sero Therapeut Res Inst Rekombinante dns, enthaltend ein herpes-simplex-virus-gen oder ein fragment davon, hefe transformiert mit dieser rekombinanten dns und verfahren zur herstellung von herpes-simplex-virus-proteinen.
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
US4659568A (en) * 1985-02-27 1987-04-21 American Cyanamid Company Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
DE3510734A1 (de) * 1985-03-25 1986-09-25 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines fuer herpes simplex virus typ 2 spezifischen antigens, dazu geeignetes mittel und verwendung dieses antigens
JPH0668B2 (ja) * 1985-08-30 1994-01-05 財団法人化学及血清療法研究所 単純ヘルペスウイルス遺伝子が組込まれた組換えプラスミド

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63224A (en) * 1980-07-17 1985-05-31 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
PT77014B (en) * 1982-07-20 1986-01-24 Molecular Genetics Inc Production of herpes simplex viral proteins
AU1678783A (en) * 1982-07-20 1984-01-26 Molecular Genetics, Inc. Production of herpes simplex viral proteins
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein

Also Published As

Publication number Publication date
ATE56044T1 (de) 1990-09-15
EP0100521B1 (de) 1990-08-29
EP0100521A3 (en) 1985-12-04
EP0100521A2 (de) 1984-02-15
DE3228501A1 (de) 1984-02-02
AU577516B2 (en) 1988-09-29
DE3381843D1 (de) 1990-10-04
AU1745283A (en) 1984-02-02
CA1273884A (en) 1990-09-11
JPS5948095A (ja) 1984-03-19

Similar Documents

Publication Publication Date Title
IL69374A0 (en) Process for the preparation of a herpes antigen,an agent suitable for this and a process for its preparation,and the use of this antigen
EP0244234A3 (en) Transformation of trichoderma
DE3377989D1 (en) Coding dna fragments for polypeptides containing at least one antigenic determinant of the papillomavirus particularly of the la hpv type and corresponding polypeptides
IL72785A (en) Herpes simplex virus vaccines based on glycoproteins and process for making them
EP0101506A4 (en) MATERIAL AND METHOD FOR HERPES SIMPLEX VIRUS Vaccination.
ES2030057T3 (es) Una silice amorfa precipitada y su metodo de preparacion.
HUT38841A (en) Process for producing compositions for producing immune-response against tumours and virus
GR3020819T3 (en) Toxoplasma gondii antigen, its production and use
AU539195B2 (en) Determination of low density lipoproteins
DE69131200D1 (en) Herpes simplex virus vp16 impfstoffe
DE3365339D1 (en) Metallic conductive (2-fluoro-5,6,11,12-tetraselenotetracene)2-bromide, process for the preparation thereof and the use thereof
PT77014A (en) Production of herpes simplex viral proteins
IL102915A (en) Soluble ldl receptor and its preparation
EP0139076A3 (en) Human-parathyroid hormone (human-pth) producing hybrid vectors, human-parathyroid hormone gene, eucaryotic cells containing the hybrid vector and their use
EP0299354A3 (en) Monoclonal antibodies against protein e7 of the human papilloma virus type 16, their production process and their use
AU1678783A (en) Production of herpes simplex viral proteins
AU8200682A (en) Process for heating coal-oil slurries
WO1990012807A3 (en) Purified, highly specific antibodies against gene products including retinoblastoma and method
AU3512793A (en) Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use
AU5507786A (en) Process for the preparation of an antigen specific to herpes simplex virus type 2, agents suitable for this purpose, and the use of this antigen
JPS5768921A (en) Thickness slip quartz oscillator
Berry Proceedings of the Annual Conference of the National Conference of States on Building Codes and Standards(NCSBCS)(8 th) Held in Santa Fe, New Mexico on April 27-May 1, 1975
McWatt The female juvenile criminalization process discriminatory enforcement?
Kulmiz The pharmacological modification of an experimentally-induced depression in the infant cynomologus monkey, Macaca fascicularis.
ZA831097B (en) Materials and methods for herpes simplex virus vaccination